Literature DB >> 17316079

Production of chimeric recombinant single domain antibody-green fluorescent fusion protein in Chinese hamster ovary cells.

M Rajabi Bazl1, M J Rasaee, M Foruzandeh, A Rahimpour, J Kiani, F Rahbarizadeh, B Alirezapour, M Mohammadi.   

Abstract

There is an increasing interest in the application of nanobodies such as VHH in the field of therapy and imaging. In the present study a stable genetically engineered cell line of Chinese hamster ovary (CHO) origin transfected using two sets of expression vectors was constructed in order to permit the cytoplasmic and extracellular expression of single domain antibody along with green fluorescent protein (GFP) as reporter gene. The quality of the constructs were examined both by the restriction map as well as sequence analysis. The gene transfection and protein expression was further examined by reverse transcription-polymerase chain reaction (RT-PCR). The transfected cells were grown in 200 microg/mL hygromycin containing media and the stable cell line obtained showed fluorescent activity for more than a period of 180 days. The production of fusion protein was also detected by fluorescent microscopy, fluorescent spectroscopy as well as by enzyme-linked immunosorbent assay (ELISA) analysis. This strategy allows a rapid production of recombinant fluobodies involving VHH, which can be used in various experiments such as imaging and detection in which a primary labeled antibody is required.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316079     DOI: 10.1089/hyb.2006.037

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  8 in total

Review 1.  Bacteriophage vehicles for phage display: biology, mechanism, and application.

Authors:  Walead Ebrahimizadeh; Masoumeh Rajabibazl
Journal:  Curr Microbiol       Date:  2014-03-18       Impact factor: 2.188

2.  An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.

Authors:  Abdolkarim Sheikhi; Mohammad Hojjat-Farsangi
Journal:  Hum Vaccin Immunother       Date:  2020-07-14       Impact factor: 3.452

3.  Module based antibody engineering: a novel synthetic REDantibody.

Authors:  Anatoliy Markiv; Bernard Anani; Ravi V Durvasula; Angray S Kang
Journal:  J Immunol Methods       Date:  2010-11-03       Impact factor: 2.303

Review 4.  Humanizing glycosylation pathways in eukaryotic expression systems.

Authors:  Amjad Hayat Khan; Hadi Bayat; Masoumeh Rajabibazl; Suriana Sabri; Azam Rahimpour
Journal:  World J Microbiol Biotechnol       Date:  2016-11-11       Impact factor: 3.312

5.  Nanobody-Targeted Photodynamic Therapy: Nanobody Production and Purification.

Authors:  Vida Mashayekhi; Erik Schooten; Paul M P van Bergen En Henegouwen; Marta M Kijanka; Sabrina Oliveira
Journal:  Methods Mol Biol       Date:  2022

Review 6.  Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection.

Authors:  Fengling Feng; Jiaoshan Chen; Jin Zhao; Yanjun Li; Minchao Li; Caijun Sun
Journal:  Viruses       Date:  2021-11-08       Impact factor: 5.048

Review 7.  Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

Authors:  Janusz Wesolowski; Vanina Alzogaray; Jan Reyelt; Mandy Unger; Karla Juarez; Mariela Urrutia; Ana Cauerhff; Welbeck Danquah; Björn Rissiek; Felix Scheuplein; Nicole Schwarz; Sahil Adriouch; Olivier Boyer; Michel Seman; Alexei Licea; David V Serreze; Fernando A Goldbaum; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Med Microbiol Immunol       Date:  2009-06-16       Impact factor: 3.402

Review 8.  Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2015-09-02       Impact factor: 5.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.